Faeth Therapeutics, Inc. (FTH) › Shareholders' EquityFaeth Therapeutics, Inc. (FTH) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$68.66M2020: -$56.44M2021: $146.51M2022: $103.41M2023: $64.89M2024: $38.39M2025: $18.59M$18.59M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$18.59M-51.6%2024$38.39M-40.8%2023$64.89M-37.2%2022$103.41M-29.4%2021$146.51M+359.6%2020-$56.44M+17.8%2019-$68.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share